Covered recipient · General Payments record
CHARLECE LYNN HUGHES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$14,036.12
- Reported across 744 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,958.75 | 113 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $353.46 | 34 |
| UCB, Inc. | $226.07 | 7 |
| PFIZER INC. | $138.30 | 22 |
| Lilly USA, LLC | $113.89 | 6 |
| Myriad Genetic Laboratories, Inc. | $95.54 | 1 |
| SK Life Science, Inc. | $88.37 | 3 |
| ACADIA Pharmaceuticals Inc | $86.30 | 3 |
| Genentech USA, Inc. | $82.43 | 3 |
| Alnylam Pharmaceuticals Inc. | $77.99 | 3 |
| Biogen, Inc. | $70.94 | 3 |
| Teva Pharmaceuticals USA, Inc. | $69.17 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.02 | 3 |
| LivaNova USA, Inc. | $59.05 | 3 |
| Kyowa Kirin, Inc. | $55.94 | 2 |
| Alexion Pharmaceuticals, Inc. | $44.09 | 2 |
| Amgen Inc. | $42.34 | 2 |
| JAZZ PHARMACEUTICALS INC. | $41.11 | 2 |
| Amneal Pharmaceuticals LLC | $33.71 | 2 |
| GENZYME CORPORATION | $33.29 | 1 |
| Abbott Laboratories | $24.82 | 1 |
| NS Pharma, Inc. | $24.31 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.27 | 1 |
| ARGENX US, INC. | $20.33 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $19.64 | 1 |
| Neurelis, Inc. | $19.28 | 1 |
| Lundbeck LLC | $17.73 | 1 |
| Axsome Therapeutics, Inc. | $17.31 | 1 |
| HARMONY BIOSCIENCES LLC | $17.05 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (114)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.